# Theron Pharmaceuticals, Inc.: Form D filings

Theron Pharmaceuticals, Inc., a pharmaceuticals company in Sunnyvale, CA, filed 4 Form D notices with the SEC between 2009 and 2015. The latest, on August 6, 2015, reports $409,099 sold of a $750,000 offering to 5 investors.

Find out what Theron Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Theron%20Pharmaceuticals%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Theron%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Ftheron-pharmaceuticals-inc-1458056)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Theron%20Pharmaceuticals%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Theron%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Ftheron-pharmaceuticals-inc-1458056)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 365 SAN ALESO AVENUE, Sunnyvale, CA, 94085
- Phone: (408) 792-7424
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1458056

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 6, 2015 | New notice | $750,000 | $409,099 | $340,901 | 5 | Jul 24, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1458056/000145805615000002/0001458056-15-000002-index.htm) |
| May 19, 2011 | New notice | $1,000,000 | $662,550 | $337,450 | 5 | May 10, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1458056/000145805611000001/0001458056-11-000001-index.htm) |
| May 14, 2010 | New notice | $2,000,000 | $957,670 | $1,042,330 | 5 | May 12, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1458056/000145805610000001/0001458056-10-000001-index.htm) |
| May 11, 2009 | New notice | $600,000 | $180,000 | $420,000 | 5 | May 5, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1458056/000145805609000001/0001458056-09-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Meenakshi Sundaram Venkatraman | Executive Officer |  |
| James W. Larrick | Director |  |
| Xiaoming R. Zhang | Executive Officer, Director |  |
| Allan W. Kramer, M.D. | Director |  |
| Jurg R. Pfister | Executive Officer, Director |  |
| Cary W. Queen, Ph.D. | Director |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of Aug 3, 2015](https://specstream.ai/data/form-d/week/2015-08-03) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Theron Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).